\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ t\\=35\\.9\\,\\ p\\=63\\,\\ r\\=20\\ bp\\=106\\/41\ \(0\)\
\-\ pt\\ is\\ follows\\ simple\\ commands\\,\\ continues\\ to\\ be\\ non\\-verbal\\,\\ perrla\\,\\ neurological\\ exam\\ is\\ grossly\\ intact\\.\\ \\ pt\\ does\\ not\\ appear\\ to\\ be\\ in\\ pain\\.\\ \\ chest\\ and\\ lung\\ exam\\ are\\ unremarkable\\,\\ no\\ apparent\\ abdominal\\ pain\\ or\\ change\\ in\\ bowel\\ or\\ bladder\\ habits\\.\\ \\ the\\ pt\\ has\\ numerous\\ scars\\ on\\ her\\ extremities\\,\\ sebaceous\\ adenomas\\ on\\ her\\ face\\,\\ as\\ well\\ as\\ a\\ shagreen\\ patch\\ on\\ her\\ forehead\\.\\ \\ there\\ are\\ areas\\ of\\ cutaneous\\ hyperpigmentation\\ on\\ her\\ back\\.\\ \ \(0\)\
\-\ cbc\\,\\ chem\\ 7\\,\\ and\\ lfts\\ are\\ all\\ normal\\.\ \(0\)\
\-\ the\\ main\\ complication\\ of\\ tuberous\\ sclerosis\\ requiring\\ long\\ term\\ therapy\\ is\\ seizure\\ disorders\\,\\ as\\ was\\ this\\ case\\ with\\ our\\ patient\\.\\ \\ she\\ was\\ placed\\ on\\ antiepileptic\\ medication\\ and\\ has\\ spent\\ much\\ of\\ her\\ childhood\\ in\\ institutions\\ due\\ to\\ her\\ behavioral\\ and\\ developmental\\ delays\\ as\\ well\\ as\\ poor\\ family\\ support\\.\\ \\ in\\ oct\\ 2006\\ she\\ had\\ a\\ peg\\ tube\\ placed\\ for\\ poor\\ feeding\\ and\\ is\\ being\\ closely\\ monitored\\ by\\ her\\ pcp\\ and\\ a\\ neurologist\\.\\ \\ standards\\ currently\\ suggest\\ follow\\-up\\ mris\\ every\\ 1\\-3\\ years\\ in\\ children\\ with\\ tuberous\\ sclerosis\\.\\ options\\ for\\ treatment\\ outside\\ of\\ antiepileptic\\ medications\\ include\\ immunosuppressive\\ therapy\\,\\ surgical\\ resection\\ such\\ as\\ focal\\ cortical\\ resection\\,\\ corpus\\ callosotomy\\ \\,\\ or\\ vagal\\ stimulation\\.\\ \\ since\\ subependymal\\ giant\\ cell\\ astrocytomas\\ are\\ associated\\ with\\ tuberous\\ sclerosis\\ and\\ can\\ cause\\ hydrocephalus\\,\\ surgical\\ resection\\ may\\ be\\ indicated\\.\ \(0\)\
\-\ mri\\ of\\ the\\ brain\\ w\\/o\\ iv\\ contrast\\.\\ \\ the\\ \\ ventricles\\ \\ are\\ increased\\ \\ slightly\\ \\ in\\ \\ size\\ \\ which\\ most\\ likely\\ represents\\ \\ mild\\ \\ atrophy\\.\\ \\ \\ \\ approximately\\ six\\ subependymal\\ lesions\\ \\ are\\ \\ identified\\ \\ in\\ the\\ lateral\\ ventricles\\ bilaterally\\ with\\ enhancement\\ \\ of\\ \\ the\\ \\ largest\\ \\ lesion\\ \\ in\\ \\ the\\ right\\ \\ lateral\\ \\ ventricle\\ \\ which\\ \\ measures\\ \\ approximately\\ \\ 1\\.1\\ \\ cm\\ \\ in\\ \\ its\\ greatest\\ \\ diameter\\.\\ \\ \\ these\\ appear\\ unchanged\\ from\\ previous\\ studies\\.\\ \\ \\ noted\\ \\ are\\ \\ the\\ \\ multiple\\ \\ areas\\ \\ of\\ \\ abnormal\\ \\ t2\\ \\ prolongation\\ \\ scattered\\ \\ throughout\\ \\ the\\ cerebral\\ \\ hemispheres\\.\\ \\ \\ \\ these\\ \\ are\\ \\ grossly\\ \\ unchanged\\ \\ when\\ compared\\ \\ with\\ previous\\ \\ studies\\.\\ \\ \\ there\\ is\\ no\\ increase\\ \\ in\\ \\ the\\ extra\\-axial\\ \\ fluid\\.\\ \\ \\ \\ there\\ \\ is\\ \\ no\\ \\ evidence\\ \\ of\\ \\ cerebellar\\ \\ ectopia\\.\\ \\ \\ \\ the\\ anterior\\ \\ pituitary\\ \\ is\\ noted\\ \\ to\\ \\ be\\ \\ concaved\\ \\ but\\ \\ is\\ \\ grossly\\ \\ unchanged\\ \\ when\\ \\ compared\\ \\ with\\ \\ previous\\ \\ studies\\.\\ \\ \\ \\ the\\ \\ corpus\\ \\ callosum\\ \\ is\\ \\ somewhat\\ \\ thin\\.\ \(0\)\
\-\ tuberous\\ sclerosis\\ \\(bourneville\\ disease\\)\ \(0\)\
\-\ complex\\ partial\\ seizures\\ \ \(2\)\
\-\ epilepsy\\ with\\ mental\\ retardation\\ \ \(0\)\
\-\ tuberous\\ sclerosis\ \(40\)\
\-\ glioblastoma\\ multiforme\\ \ \(1\)\
\-\ hydrocephalus\\ \ \(74\)\
\-\ infantile\\ spasm\\ \\(west\\ syndrome\\)\\ \ \(0\)\
\-\ lennox\\-gastaut\\ syndrome\\ \ \(0\)\
\-\ giant\\ cell\\ astrocytoma\ \(5\)\
\-\ 16\\ y\\/o\\ white\\ female\\ presented\\ to\\ the\\ er\\ with\\ her\\ mother\\ with\\ c\\/o\\ increasing\\ seizure\\ activity\\,\\ increased\\ self\\-mutilation\\,\\ and\\ violence\\ towards\\ others\\.\\ \\ pt\\ has\\ longstanding\\ hx\\ of\\ problems\\ since\\ birth\\ to\\ include\\ autism\\,\\ mental\\ retardation\\ and\\ developmental\\ delay\\,\\ as\\ well\\ as\\ sz\\ disorder\\.\\ the\\ pt\\ is\\ non\\-verbal\\.\\ the\\ patient\\ was\\ being\\ followed\\ at\\ another\\ facility\\,\\ however\\,\\ due\\ to\\ a\\ recent\\ move\\,\\ her\\ family\\ now\\ wishes\\ to\\ have\\ her\\ care\\ managed\\ at\\ your\\ facility\ \(0\)\
\-\ as\\ is\\ the\\ case\\ with\\ more\\ than\\ 90\\ percent\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\,\\ this\\ patient\\ presented\\ with\\ seizures\\.\\ \\ though\\ her\\ underlying\\ hx\\ of\\ seizures\\ disorder\\ complicates\\ the\\ picture\\,\\ it\\ is\\ likely\\ that\\ some\\ of\\ the\\ problems\\ she\\ is\\ having\\ are\\ manifestations\\ of\\ her\\ tuberous\\ sclerosis\\.\\ \\ in\\ addition\\,\\ this\\ patient\\,\\ like\\ 50\\-85\\ percent\\ of\\ those\\ affected\\ by\\ tuberous\\ sclerosis\\,\\ had\\ severe\\ developmental\\ delay\\.\\ \\ she\\ also\\ had\\ the\\ skin\\ manifestation\\ that\\ are\\ characteristic\\ in\\ more\\ than\\ 80\\ percent\\ of\\ patient\\'s\\ to\\ include\\ shagreen\\ patches\\ and\\ sebaceous\\ adenomas\\ on\\ her\\ face\\.\\ \\ this\\ patient\\'s\\ condition\\ was\\ being\\ managed\\ conservatively\\ with\\ antiepileptic\\ medication\\ and\\ routine\\ follow\\-up\\ mris\\.\\ interestingly\\,\\ within\\ the\\ past\\ year\\ the\\ patient\\ also\\ had\\ renal\\ us\\ done\\ due\\ to\\ possible\\ renal\\ cysts\\ versus\\ tumors\\,\\ which\\ can\\ be\\ found\\ in\\ up\\ to\\ 80\\ percent\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\.\\ \\ however\\,\\ at\\ the\\ time\\ of\\ this\\ posting\\,\\ the\\ final\\ results\\ are\\ not\\ known\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberous\\:\\ 0\\.32760593423411344\ \(0\)\
\-\ her\\:\\ 0\\.2964566325800885\ \(0\)\
\-\ sclerosis\\:\\ 0\\.23399598768014843\ \(0\)\
\-\ the\\:\\ 0\\.16751968175898235\ \(0\)\
\-\ antiepileptic\\:\\ 0\\.15403385045556162\ \(0\)\
\-\ are\\:\\ 0\\.1523591869903902\ \(0\)\
\-\ percent\\:\\ 0\\.14439316122652399\ \(0\)\
\-\ as\\:\\ 0\\.13197720911727276\ \(0\)\
\-\ pt\\:\\ 0\\.13134621047043624\ \(0\)\
\-\ is\\:\\ 0\\.1299520403275719\ \(0\)\
\-\ unchanged\\:\\ 0\\.12189875414850374\ \(0\)\
\-\ of\\:\\ 0\\.12143563691507897\ \(0\)\
\-\ in\\:\\ 0\\.11804655156467324\ \(0\)\
\-\ shagreen\\:\\ 0\\.10787833906564691\ \(0\)\
\-\ grossly\\:\\ 0\\.10504257386232961\ \(0\)\
\-\ to\\:\\ 0\\.10037961187339413\ \(0\)\
\-\ with\\:\\ 0\\.1000655720887523\ \(0\)\
\-\ developmental\\:\\ 0\\.09469553186529511\ \(0\)\
\-\ sebaceous\\:\\ 0\\.0901366704212173\ \(0\)\
\-\ mris\\:\\ 0\\.0901366704212173\ \(0\)\
\-\ seizures\\:\\ 0\\.08939233363319425\ \(0\)\
\-\ she\\:\\ 0\\.0869149977203158\ \(0\)\
\-\ retardation\\:\\ 0\\.08549223905162084\ \(0\)\
\-\ adenomas\\:\\ 0\\.08494756499261147\ \(0\)\
\-\ patient\\:\\ 0\\.08310579479837178\ \(0\)\
\-\ and\\:\\ 0\\.08296952331057028\ \(0\)\
\-\ previous\\:\\ 0\\.08274491614713637\ \(0\)\
\-\ studies\\:\\ 0\\.08032841030889809\ \(0\)\
\-\ subependymal\\:\\ 0\\.07778565323981382\ \(0\)\
\-\ being\\:\\ 0\\.07630801367399435\ \(0\)\
\-\ be\\:\\ 0\\.0740369373207074\ \(0\)\
\-\ had\\:\\ 0\\.07274648186779141\ \(0\)\
\-\ facility\\:\\ 0\\.07239500177678769\ \(0\)\
\-\ managed\\:\\ 0\\.0714322993008002\ \(0\)\
\-\ resection\\:\\ 0\\.07019470101701668\ \(0\)\
\-\ medication\\:\\ 0\\.067475335956608\ \(0\)\
\-\ delay\\:\\ 0\\.0669420125934072\ \(0\)\
\-\ corpus\\:\\ 0\\.06655611676431718\ \(0\)\
\-\ hx\\:\\ 0\\.06643002797409991\ \(0\)\
\-\ on\\:\\ 0\\.06614531776997214\ \(0\)\
\-\ face\\:\\ 0\\.06581757098503122\ \(0\)\
\-\ include\\:\\ 0\\.0651550084736961\ \(0\)\
\-\ giant\\:\\ 0\\.06511933008663652\ \(0\)\
\-\ ventricles\\:\\ 0\\.06413858505776801\ \(0\)\
\-\ mental\\:\\ 0\\.06362454372352096\ \(0\)\
\-\ problems\\:\\ 0\\.06332574629104719\ \(0\)\
\-\ due\\:\\ 0\\.0629460383111156\ \(0\)\
\-\ this\\:\\ 0\\.06271366062387186\ \(0\)\
\-\ disorder\\:\\ 0\\.06175290716480135\ \(0\)\
\-\ poor\\:\\ 0\\.06157995982090811\ \(0\)\
\-\ seizure\\:\\ 0\\.06074863459600042\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.05959488908879616\ \(0\)\
\-\ compared\\:\\ 0\\.05901960533166157\ \(0\)\
\-\ appear\\:\\ 0\\.05749661206661804\ \(0\)\
\-\ family\\:\\ 0\\.05743433501581742\ \(0\)\
\-\ 80\\:\\ 0\\.05694673666281642\ \(0\)\
\-\ placed\\:\\ 0\\.056887072644798996\ \(0\)\
\-\ callosotomy\\:\\ 0\\.05578003397962795\ \(0\)\
\-\ concaved\\:\\ 0\\.05578003397962795\ \(0\)\
\-\ posting\\:\\ 0\\.05578003397962795\ \(0\)\
\-\ up\\:\\ 0\\.054168438214069\ \(0\)\
\-\ bourneville\\:\\ 0\\.053939169532823454\ \(0\)\
\-\ violence\\:\\ 0\\.053939169532823454\ \(0\)\
\-\ sz\\:\\ 0\\.053939169532823454\ \(0\)\
\-\ well\\:\\ 0\\.05302329250525962\ \(0\)\
\-\ since\\:\\ 0\\.052882072842586544\ \(0\)\
\-\ standards\\:\\ 0\\.05251128413611744\ \(0\)\
\-\ autism\\:\\ 0\\.05251128413611744\ \(0\)\
\-\ wishes\\:\\ 0\\.05251128413611744\ \(0\)\
\-\ complicates\\:\\ 0\\.05251128413611744\ \(0\)\
\-\ behavioral\\:\\ 0\\.05134461681852054\ \(0\)\
\-\ immunosuppressive\\:\\ 0\\.05134461681852054\ \(0\)\
\-\ was\\:\\ 0\\.05088518314992922\ \(0\)\
\-\ hyperpigmentation\\:\\ 0\\.050358213656424636\ \(0\)\
\-\ delays\\:\\ 0\\.050358213656424636\ \(0\)\
\-\ peg\\:\\ 0\\.050358213656424636\ \(0\)\
\-\ has\\:\\ 0\\.050019100523514284\ \(0\)\
\-\ which\\:\\ 0\\.0497934184177186\ \(0\)\
\-\ areas\\:\\ 0\\.04956460397270033\ \(0\)\
\-\ institutions\\:\\ 0\\.04950375237171606\ \(0\)\
\-\ spent\\:\\ 0\\.04875006410421762\ \(0\)\
\-\ vagal\\:\\ 0\\.04807586697501004\ \(0\)\
\-\ habits\\:\\ 0\\.046909199657413136\ \(0\)\
\-\ approximately\\:\\ 0\\.04658182233530492\ \(0\)\
\-\ patches\\:\\ 0\\.04639701002555182\ \(0\)\
\-\ west\\:\\ 0\\.04592279649531723\ \(0\)\
\-\ commands\\:\\ 0\\.04548131426070712\ \(0\)\
\-\ epilepsy\\:\\ 0\\.04548131426070712\ \(0\)\
\-\ renal\\:\\ 0\\.045461608686345314\ \(0\)\
\-\ prolongation\\:\\ 0\\.044680401023567684\ \(0\)\
\-\ neurologist\\:\\ 0\\.04431464694311022\ \(0\)\
\-\ when\\:\\ 0\\.044098596598031135\ \(0\)\
\-\ syndrome\\:\\ 0\\.04401123852037174\ \(0\)\
\-\ patch\\:\\ 0\\.04364044981390263\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.04364044981390263\ \(0\)\
\-\ likely\\:\\ 0\\.043625342691281724\ \(0\)\
\-\ there\\:\\ 0\\.0435720543972814\ \(0\)\
\-\ however\\:\\ 0\\.04320978966868424\ \(0\)\
\-\ scars\\:\\ 0\\.04274611952581042\ \(0\)\
\-\ your\\:\\ 0\\.04274611952581042\ \(0\)\
\-\ presented\\:\\ 0\\.042571755559380746\ \(0\)\
\-\ longstanding\\:\\ 0\\.042473782496305734\ \(0\)\
\-\ interestingly\\:\\ 0\\.042473782496305734\ \(0\)\
\-\ lfts\\:\\ 0\\.04221256441719661\ \(0\)\
\-\ oct\\:\\ 0\\.04221256441719661\ \(0\)\
\-\ therapy\\:\\ 0\\.04194549127438309\ \(0\)\
\-\ cell\\:\\ 0\\.04176161011270977\ \(0\)\
\-\ chem\\:\\ 0\\.041720094228807306\ \(0\)\
\-\ infantile\\:\\ 0\\.041720094228807306\ \(0\)\
\-\ perrla\\:\\ 0\\.041487379334209824\ \(0\)\
\-\ forehead\\:\\ 0\\.041487379334209824\ \(0\)\
\-\ ectopia\\:\\ 0\\.041487379334209824\ \(0\)\
\-\ move\\:\\ 0\\.041487379334209824\ \(0\)\
\-\ manifestation\\:\\ 0\\.041487379334209824\ \(0\)\
\-\ than\\:\\ 0\\.04138385101878981\ \(0\)\
\-\ at\\:\\ 0\\.04136176154458236\ \(0\)\
\-\ these\\:\\ 0\\.04122530641969949\ \(0\)\
\-\ patients\\:\\ 0\\.04106870191200654\ \(0\)\
\-\ pcp\\:\\ 0\\.04083607652045334\ \(0\)\
\-\ stimulation\\:\\ 0\\.04024498386246028\ \(0\)\
\-\ more\\:\\ 0\\.040086964615881654\ \(0\)\
\-\ towards\\:\\ 0\\.040059493937503805\ \(0\)\
\-\ increased\\:\\ 0\\.03947705270163196\ \(0\)\
\-\ closely\\:\\ 0\\.03920503265279523\ \(0\)\
\-\ monitored\\:\\ 0\\.03920503265279523\ \(0\)\
\-\ noted\\:\\ 0\\.0387065755690895\ \(0\)\
\-\ others\\:\\ 0\\.03845134438529679\ \(0\)\
\-\ picture\\:\\ 0\\.03831070236470301\ \(0\)\
\-\ can\\:\\ 0\\.03831014847245864\ \(0\)\
\-\ or\\:\\ 0\\.03809514976473649\ \(0\)\
\-\ multiforme\\:\\ 0\\.03803836533519833\ \(0\)\
\-\ cutaneous\\:\\ 0\\.037906423457811\ \(0\)\
\-\ manifestations\\:\\ 0\\.03740428717341053\ \(0\)\
\-\ largest\\:\\ 0\\.03716726176713601\ \(0\)\
\-\ childhood\\:\\ 0\\.03693870338735997\ \(0\)\
\-\ spasm\\:\\ 0\\.03693870338735997\ \(0\)\
\-\ exam\\:\\ 0\\.03675021371704166\ \(0\)\
\-\ conservatively\\:\\ 0\\.03671802792122957\ \(0\)\
\-\ case\\:\\ 0\\.036676379423680835\ \(0\)\
\-\ greatest\\:\\ 0\\.03650470968999141\ \(0\)\
\-\ requiring\\:\\ 0\\.03640065935934594\ \(0\)\
\-\ 2006\\:\\ 0\\.03640065935934594\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.03640065935934594\ \(0\)\
\-\ lateral\\:\\ 0\\.03623024605312853\ \(0\)\
\-\ final\\:\\ 0\\.03580956670135288\ \(0\)\
\-\ follows\\:\\ 0\\.0357161496504001\ \(0\)\
\-\ no\\:\\ 0\\.03561006989264624\ \(0\)\
\-\ surgical\\:\\ 0\\.03548229024994818\ \(0\)\
\-\ support\\:\\ 0\\.03544381262089542\ \(0\)\
\-\ hemispheres\\:\\ 0\\.03544381262089542\ \(0\)\
\-\ every\\:\\ 0\\.03535554978233777\ \(0\)\
\-\ continues\\:\\ 0\\.03485010654471508\ \(0\)\
\-\ atrophy\\:\\ 0\\.034534044558505735\ \(0\)\
\-\ callosum\\:\\ 0\\.03438168130464686\ \(0\)\
\-\ also\\:\\ 0\\.034338955346469434\ \(0\)\
\-\ feeding\\:\\ 0\\.03423286170550549\ \(0\)\
\-\ pituitary\\:\\ 0\\.03366995354384946\ \(0\)\
\-\ somewhat\\:\\ 0\\.03321501398704996\ \(0\)\
\-\ complication\\:\\ 0\\.03315258466901612\ \(0\)\
\-\ simple\\:\\ 0\\.03302952406209348\ \(0\)\
\-\ options\\:\\ 0\\.03290878549251561\ \(0\)\
\-\ six\\:\\ 0\\.03279028295138456\ \(0\)\
\-\ represents\\:\\ 0\\.03261654501199502\ \(0\)\
\-\ birth\\:\\ 0\\.03261654501199502\ \(0\)\
\-\ our\\:\\ 0\\.032337070274731185\ \(0\)\
\-\ versus\\:\\ 0\\.03228261076012216\ \(0\)\
\-\ vitals\\:\\ 0\\.032228610824954054\ \(0\)\
\-\ disorders\\:\\ 0\\.032228610824954054\ \(0\)\
\-\ main\\:\\ 0\\.03181227186176048\ \(0\)\
\-\ scattered\\:\\ 0\\.03176208372728645\ \(0\)\
\-\ though\\:\\ 0\\.03171228616591001\ \(0\)\
\-\ that\\:\\ 0\\.031680966859291795\ \(0\)\
\-\ much\\:\\ 0\\.03161383877269151\ \(0\)\
\-\ having\\:\\ 0\\.031468950597766346\ \(0\)\
\-\ those\\:\\ 0\\.031234530452168074\ \(0\)\
\-\ mother\\:\\ 0\\.031188659615288997\ \(0\)\
\-\ by\\:\\ 0\\.03100170173757869\ \(0\)\
\-\ numerous\\:\\ 0\\.030833070674924093\ \(0\)\
\-\ medications\\:\\ 0\\.03062046127274704\ \(0\)\
\-\ apparent\\:\\ 0\\.030537356801532516\ \(0\)\
\-\ cbc\\:\\ 0\\.030455317801634203\ \(0\)\
\-\ indicated\\:\\ 0\\.030021992297692097\ \(0\)\
\-\ affected\\:\\ 0\\.030021992297692097\ \(0\)\
\-\ neurological\\:\\ 0\\.02998401619606538\ \(0\)\
\-\ children\\:\\ 0\\.029908733511949642\ \(0\)\
\-\ cerebellar\\:\\ 0\\.029871421719105517\ \(0\)\
\-\ another\\:\\ 0\\.029871421719105517\ \(0\)\
\-\ underlying\\:\\ 0\\.02979744454439808\ \(0\)\
\-\ measures\\:\\ 0\\.02976077421858298\ \(0\)\
\-\ suggest\\:\\ 0\\.029652007503465576\ \(0\)\
\-\ addition\\:\\ 0\\.02954505870180864\ \(0\)\
\-\ characteristic\\:\\ 0\\.029509802665830785\ \(0\)\
\-\ diameter\\:\\ 0\\.029336378654586256\ \(0\)\
\-\ outside\\:\\ 0\\.029302250817196604\ \(0\)\
\-\ increase\\:\\ 0\\.029302250817196604\ \(0\)\
\-\ tube\\:\\ 0\\.02916753101298352\ \(0\)\
\-\ 90\\:\\ 0\\.02916753101298352\ \(0\)\
\-\ condition\\:\\ 0\\.02916753101298352\ \(0\)\
\-\ us\\:\\ 0\\.02903558913559619\ \(0\)\
\-\ done\\:\\ 0\\.02903558913559619\ \(0\)\
\-\ not\\:\\ 0\\.028820214073205983\ \(0\)\
\-\ increasing\\:\\ 0\\.02874830603330902\ \(0\)\
\-\ term\\:\\ 0\\.028624650893788853\ \(0\)\
\-\ slightly\\:\\ 0\\.02847336833140821\ \(0\)\
\-\ 16\\:\\ 0\\.028443536322399498\ \(0\)\
\-\ results\\:\\ 0\\.028443536322399498\ \(0\)\
\-\ thin\\:\\ 0\\.028413842745485092\ \(0\)\
\-\ bladder\\:\\ 0\\.028325579906927453\ \(0\)\
\-\ routine\\:\\ 0\\.028267407194081242\ \(0\)\
\-\ complex\\:\\ 0\\.028124247882210855\ \(0\)\
\-\ partial\\:\\ 0\\.028124247882210855\ \(0\)\
\-\ currently\\:\\ 0\\.028039864843894917\ \(0\)\
\-\ extremities\\:\\ 0\\.02773964561627751\ \(0\)\
\-\ change\\:\\ 0\\.027660154477986663\ \(0\)\
\-\ cysts\\:\\ 0\\.027660154477986663\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.027555679433283846\ \(0\)\
\-\ er\\:\\ 0\\.02730171934416102\ \(0\)\
\-\ skin\\:\\ 0\\.027154044613179006\ \(0\)\
\-\ like\\:\\ 0\\.027129760127324303\ \(0\)\
\-\ its\\:\\ 0\\.027009701176922113\ \(0\)\
\-\ ventricle\\:\\ 0\\.026868542048215184\ \(0\)\
\-\ throughout\\:\\ 0\\.02684531532818529\ \(0\)\
\-\ tumors\\:\\ 0\\.02684531532818529\ \(0\)\
\-\ activity\\:\\ 0\\.026799113291060668\ \(0\)\
\-\ intact\\:\\ 0\\.02641930820230874\ \(0\)\
\-\ cortical\\:\\ 0\\.026205989971070584\ \(0\)\
\-\ pain\\:\\ 0\\.02612349197018929\ \(0\)\
\-\ iv\\:\\ 0\\.026081331074004427\ \(0\)\
\-\ care\\:\\ 0\\.026081331074004427\ \(0\)\
\-\ identified\\:\\ 0\\.025878815617105283\ \(0\)\
\-\ cerebral\\:\\ 0\\.025288895680519816\ \(0\)\
\-\ does\\:\\ 0\\.025234590225795554\ \(0\)\
\-\ now\\:\\ 0\\.025056830063416947\ \(0\)\
\-\ cause\\:\\ 0\\.024866833656089198\ \(0\)\
\-\ possible\\:\\ 0\\.024732113851876122\ \(0\)\
\-\ size\\:\\ 0\\.024715471568522374\ \(0\)\
\-\ recent\\:\\ 0\\.024715471568522374\ \(0\)\
\-\ followed\\:\\ 0\\.024649331916730743\ \(0\)\
\-\ unremarkable\\:\\ 0\\.024470895772767003\ \(0\)\
\-\ back\\:\\ 0\\.024344179664835153\ \(0\)\
\-\ bilaterally\\:\\ 0\\.024344179664835153\ \(0\)\
\-\ long\\:\\ 0\\.024204560576757753\ \(0\)\
\-\ white\\:\\ 0\\.024082961585726034\ \(0\)\
\-\ past\\:\\ 0\\.02376001003504373\ \(0\)\
\-\ known\\:\\ 0\\.023632451904037757\ \(0\)\
\-\ found\\:\\ 0\\.023618434473804538\ \(0\)\
\-\ such\\:\\ 0\\.023479923560607206\ \(0\)\
\-\ bowel\\:\\ 0\\.023425347926223885\ \(0\)\
\-\ severe\\:\\ 0\\.023107322016315365\ \(0\)\
\-\ some\\:\\ 0\\.022966679995721585\ \(0\)\
\-\ brain\\:\\ 0\\.022755227862679934\ \(0\)\
\-\ years\\:\\ 0\\.022375215402807753\ \(0\)\
\-\ lung\\:\\ 0\\.022204566507331738\ \(0\)\
\-\ for\\:\\ 0\\.022126930203000817\ \(0\)\
\-\ abnormal\\:\\ 0\\.021929891106033224\ \(0\)\
\-\ focal\\:\\ 0\\.021833824932979844\ \(0\)\
\-\ all\\:\\ 0\\.02172874943007895\ \(0\)\
\-\ time\\:\\ 0\\.021635634465959345\ \(0\)\
\-\ fluid\\:\\ 0\\.021075429821324647\ \(0\)\
\-\ enhancement\\:\\ 0\\.021009894968484596\ \(0\)\
\-\ t2\\:\\ 0\\.021000587396890712\ \(0\)\
\-\ lesions\\:\\ 0\\.02096349190551001\ \(0\)\
\-\ cm\\:\\ 0\\.02096349190551001\ \(0\)\
\-\ evidence\\:\\ 0\\.020718569355005715\ \(0\)\
\-\ mild\\:\\ 0\\.020691925509394905\ \(0\)\
\-\ anterior\\:\\ 0\\.02038056361005343\ \(0\)\
\-\ abdominal\\:\\ 0\\.019963892297527316\ \(0\)\
\-\ chest\\:\\ 0\\.019267586222141014\ \(0\)\
\-\ associated\\:\\ 0\\.019239272218676925\ \(0\)\
\-\ most\\:\\ 0\\.018996727318429465\ \(0\)\
\-\ mri\\:\\ 0\\.018736869416675364\ \(0\)\
\-\ it\\:\\ 0\\.018684845111069038\ \(0\)\
\-\ may\\:\\ 0\\.018368939191207096\ \(0\)\
\-\ have\\:\\ 0\\.0182347331322749\ \(0\)\
\-\ but\\:\\ 0\\.01805027816233202\ \(0\)\
\-\ multiple\\:\\ 0\\.017853904947455146\ \(0\)\
\-\ contrast\\:\\ 0\\.017735558957580822\ \(0\)\
\-\ female\\:\\ 0\\.017613881137908162\ \(0\)\
\-\ lesion\\:\\ 0\\.017499853478107393\ \(0\)\
\-\ treatment\\:\\ 0\\.017387822237047174\ \(0\)\
\-\ within\\:\\ 0\\.0168116789584051\ \(0\)\
\-\ disease\\:\\ 0\\.015322227681201592\ \(0\)\
\-\ normal\\:\\ 0\\.01490350708352851\ \(0\)\
\-\ from\\:\\ 0\\.014497032517978105\ \(0\)\
\-\ right\\:\\ 0\\.012101911314976737\ \(0\)\
\-\ year\\:\\ 0\\.01124918659575241\ \(0\)\
